Adaptive Biotechnologies Corp

10-Year Study

ADPT.US · Healthcare · US · Common Stock

Executive Summary: Adaptive Biotechnologies Corp has compounded at -16.5% annually over the last 10 years, with a maximum drawdown of 95.6% and an annualized volatility of 101.0%.

1Y CAGR
+53.2%
3Y CAGR
+27.3%
5Y CAGR
-18.2%
10Y CAGR
-16.5%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
95.6%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
-0.07
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
-0.11
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
59.5%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2025 · +170.9%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2022 · -72.8%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
43%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
202613.9-13.4-13.41.4————————-13.3%
202529.36.6-10.0-0.929.322.4-12.128.713.516.013.2-17.4170.9%
2024-25.112.0-21.9-18.431.74.925.73.38.9-5.522.70.922.3%
202321.3-7.83.3-19.1-2.5-3.625.8-19.8-19.5-18.5-1.411.9-35.9%
2022-37.8-17.3-3.8-40.6-5.23.513.2-2.6-20.29.312.9-13.0-72.8%
2021-6.22.0-28.83.3-9.18.1-10.3-0.9-6.4-1.7-21.97.6-52.5%
2020-0.1-6.0-1.115.220.925.0-22.911.516.9-5.24.622.697.6%
2019——————-20.231.9-39.2-15.64.310.0-38.1%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 101.0%. The dominant macroeconomic risk driver is SHV.US, accounting for 63.1% of variance. Idiosyncratic stock-specific factors contribute 16.2%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2019-06-0110000
2019-07-017981.366459627329
2019-08-0110527.950310559007
2019-09-016397.515527950311
2019-10-015396.48033126294
2019-11-015629.3995859213255
2019-12-016194.6169772256735
2020-01-016191.511387163562
2020-02-015817.805383022775
2020-03-015751.552795031056
2020-04-016627.329192546584
2020-05-018012.422360248448
2020-06-0110016.56314699793
2020-07-017726.708074534162
2020-08-018614.906832298137
2020-09-0110068.32298136646
2020-10-019540.372670807454
2020-11-019983.436853002071
2020-12-0112242.236024844722
2021-01-0111484.47204968944
2021-02-0111712.215320910975
2021-03-018335.403726708075
2021-04-018612.836438923396
2021-05-017828.157349896481
2021-06-018459.627329192548
2021-07-017590.062111801242
2021-08-017519.668737060042
2021-09-017037.267080745342
2021-10-016917.184265010352
2021-11-015401.656314699793
2021-12-015809.52380952381
2022-01-013610.7660455486543
2022-02-012987.577639751553
2022-03-012873.7060041407867
2022-04-011708.0745341614909
2022-05-011619.047619047619
2022-06-011674.9482401656314
2022-07-011896.48033126294
2022-08-011846.7908902691513
2022-09-011474.120082815735
2022-10-011610.7660455486543
2022-11-011817.805383022774
2022-12-011581.7805383022774
2023-01-011919.254658385093
2023-02-011770.186335403727
2023-03-011828.1573498964804
2023-04-011478.2608695652175
2023-05-011440.993788819876
2023-06-011389.2339544513457
2023-07-011747.4120082815737
2023-08-011401.6563146997928
2023-09-011128.3643892339546
2023-10-01919.2546583850933
2023-11-01906.8322981366459
2023-12-011014.4927536231885
2024-01-01759.8343685300207
2024-02-01850.9316770186336
2024-03-01664.5962732919255
2024-04-01542.4430641821947
2024-05-01714.2857142857143
2024-06-01749.4824016563148
2024-07-01942.0289855072464
2024-08-01973.0848861283645
2024-09-011060.0414078674949
2024-10-011002.0703933747413
2024-11-011229.8136645962734
2024-12-011241.20082815735
2025-01-011604.5548654244308
2025-02-011710.1449275362318
2025-03-011538.3022774327123
2025-04-011523.8095238095239
2025-05-011971.0144927536232
2025-06-012412.008281573499
2025-07-012120.0828157349897
2025-08-012728.7784679089027
2025-09-013097.3084886128368
2025-10-013594.2028985507245
2025-11-014070.393374741201
2025-12-013362.31884057971
2026-01-013830.2277432712217
2026-02-013316.7701863354037
2026-03-012873.7060041407867
2026-04-012915.1138716356113
Annual Return Matrix
YearAnnual Return
20200.9762700534759359
2021-0.5254523930323017
2022-0.7277263007840342
2023-0.3586387434554973
20240.22346938775510194
20251.7089241034195162
2026-0.13300492610837433
Total Factor Risk
1.0101013266949923
VTI.US Exposure
-0.03821473178138587
VEA.US Exposure
-0.03931253695794591
VWO.US Exposure
0.06180820997192263
QQQ.US Exposure
0.05644017441554329
VTV.US Exposure
-0.031537524995663355
IJR.US Exposure
0.08295403621213775
QUAL.US Exposure
0.028468940216792547
SHV.US Exposure
0.6313908378156061
TLT.US Exposure
-0.0019789477778408694
LQD.US Exposure
0.030470346382136065
HYG.US Exposure
0.012972973063456612
GLD.US Exposure
0.00014322800226171612
USO.US Exposure
0.0018086292550396927
VNQ.US Exposure
0.022661811490216587
BTC-USD.CC Exposure
-0.007788206622643899
CPER.US Exposure
0.0013761855660549326
VIX.INDX Exposure
0.021257036706474348
UUP.US Exposure
0.006185085980876678
TIP.US Exposure
-0.0014114999875190406
Idiosyncratic Exposure
0.16230595304448006
Value Score
50
Growth Score
50
Profit Score
37.5
Health Score
23.6
Yield Score
0
Moat Score
40

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
101.0%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →N/A
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →0.00%
Market Cap$2.3B
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
0.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
1.18
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators relative to key technical levels: distance from 50-Day SMA (intermediate trend), 200-Day SMA (long-term trend), 52-Week High (bullish proximity), and Beta (market sensitivity coefficient).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-4.5%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-4.6%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
31.2% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
2.30
Market sensitivity coefficient

Frequently Asked Questions & Methodology

Is Adaptive Biotechnologies Corp a high-risk investment?

Adaptive Biotechnologies Corp (ADPT.US) has an annualized volatility of 101.0% and experienced a maximum drawdown of 95.6% over the last 10 years. Its primary macro risk driver is SHV.US.

What is the 10-year return of ADPT.US?

Over the past 10 years, ADPT.US has generated a Compound Annual Growth Rate (CAGR) of -16.5%. It has had a positive return in 43% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on Adaptive Biotechnologies Corp

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest